George Kemble
Net worth: 616 637 $ as of 2026-10-30
Net worth: 616 637 $ as of 2026-10-30
George W.
Kemble is Executive Chairman at Sagimet Biosciences, Inc. since 2022.
Formerly, Dr. Kemble was Senior Vice President-Research & Development at MedImmune LLC from 2001 to 2011.
Other former roles include Director at LigoCyte Pharmaceuticals, Inc. and Staff Scientist at MedImmune Vaccines, Inc. Education includes a doctorate from Stanford University and an undergraduate degree from Santa Clara University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-13 | 62,161 ( 0.09% ) | 616 637 $ | 2026-10-30 |
| Companies | Position | Start |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Chairman | 2022-10-23 |
| Companies | Position | End |
|---|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Chief Tech/Sci/R&D Officer | 2010-12-31 |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Corporate Officer/Principal | - |
LigoCyte Pharmaceuticals, Inc.
LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology Develops, manufactures and markets live vaccines | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santa Clara University
Santa Clara University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LigoCyte Pharmaceuticals, Inc.
LigoCyte Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Developed vaccines and monoclonal antibody therapeutics | Health Technology |
Sagimet Biosciences, Inc.
Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions